HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Young, L S Articles by Eliopoulos, A G Search for Related Content PubMed PubMed Citation Articles by Young, L S Articles by Eliopoulos, A G

The expression and function of Epstein-Barr virus encoded latent genes

¹ CRC Institute for Cancer Studies, University of Birmingham Medical School, Birmingham B15 2TA, UK

Correspondence: Professor Young L.S.Young{at}bham.ac.uk

The association of Epstein-Barr virus (EBV) with various malignancies is well established but the pattern of EBV latent gene expression in these different tumours is variable, reflecting distinct aspects of the virus–cell interaction. These different forms of EBV latency are associated with phenotypic variation and highlight the influence of EBV latent proteins on cell growth and survival. The EBV latent proteins have distinct functions associated with the maintenance of EBV infection and the control of various signalling and transcriptional pathways that facilitate the proliferation and survival of infected cells. Understanding the function of these EBV latent proteins will not only provide insight into the mechanisms governing fundamental cell processes but will also identify targets for novel treatment.

Key Words: Epstein-Barr virus • EBV latent genes

This article has been cited by other articles:

				C. Le Clorennec, T.-S. Ouk, I. Youlyouz-Marfak, S. Panteix, C.-C. Martin, J. Rastelli, E. Adriaenssens, U. Zimber-Strobl, J. Coll, J. Feuillard, et al. Molecular Basis of Cytotoxicity of Epstein-Barr Virus (EBV) Latent Membrane Protein 1 (LMP1) in EBV Latency III B Cells: LMP1 Induces Type II Ligand-Independent Autoactivation of CD95/Fas with Caspase 8-Mediated Apoptosis J. Virol., July 1, 2008; 82(13): 6721 - 6733. [Abstract] [Full Text] [PDF]

				R. Kaul, M. Murakami, T. Choudhuri, and E. S. Robertson Epstein-Barr Virus Latent Nuclear Antigens Can Induce Metastasis in a Nude Mouse Model J. Virol., October 1, 2007; 81(19): 10352 - 10361. [Abstract] [Full Text] [PDF]

				P. A. Madureira, P. Matos, I. Soeiro, L. K. Dixon, J. P. Simas, and E. W.-F. Lam Murine {gamma}-Herpesvirus 68 Latency Protein M2 Binds to Vav Signaling Proteins and Inhibits B-cell Receptor-induced Cell Cycle Arrest and Apoptosis in WEHI-231 B Cells J. Biol. Chem., November 11, 2005; 280(45): 37310 - 37318. [Abstract] [Full Text] [PDF]

				F. Pages, J. Galon, G. Karaschuk, D. Dudziak, M. Camus, V. Lazar, S. Camilleri-Broet, C. Lagorce-Pages, S. Lebel-Binay, G. Laux, et al. Epstein-Barr virus nuclear antigen 2 induces interleukin-18 receptor expression in B cells Blood, February 15, 2005; 105(4): 1632 - 1639. [Abstract] [Full Text] [PDF]

				Z. Lin, Q. Yin, and E. Flemington Identification of a Negative Regulatory Element in the Epstein-Barr Virus Zta Transactivation Domain That Is Regulated by the Cell Cycle Control Factors c-Myc and E2F1 J. Virol., November 1, 2004; 78(21): 11962 - 11971. [Abstract] [Full Text] [PDF]

				C. E. Tune, M. Pilon, Y. Saiki, and H.-M. Dosch Sustained Expression of the Novel EBV-Induced Zinc Finger Gene, ZNFEB, Is Critical for the Transition of B Lymphocyte Activation to Oncogenic Growth Transformation J. Immunol., January 15, 2002; 168(2): 680 - 688. [Abstract] [Full Text] [PDF]

				P G Murray and L S Young Themed issue: the biology and pathology of the Epstein-Barr virus Mol. Pathol., October 1, 2000; 53(5): 219 - 221. [Full Text]